Myocarditis Clinical Trial
Official title:
Acute Myocarditis Registry With Prognostic, Histologic, Immunologic, Biological, Imaging and Clinical Assessment
The AMPHIBIA study is an observational ambispective and prospective cohort that aim to describe the histologic, immunologic, biological, imaging, genetic and clinical characteristics of the patients hospitalized for an acute myocarditis and to evaluate their association with prognosis.
Acute myocarditis is an inflammatory disease of the heart muscle. Its clinical presentation and its etiologies are multiple and make it a complex disease to treat. Its course also varies, ranging from complete clinical recovery to recurrence of ventricular arrhythmia or progression to chronic dilated heart disease, while being difficult to predict. The long-term prognosis is poorly understood. Consecutive patients hospitalized in a tertiary university referral center cohort from 2006 to 2041 for an acute myocarditis will be ambispectively or prospectively analyzed. This project will establish a registry including up to 400 patients in the ambispective analysis cohort from 2006 to 2021 and 1000 patients in the prospective analysis cohort during a 20 years inclusion period. The aim of the study is to describe the characteristics of patients hospitalized for an acute myocarditis and to evaluate their association wih the long term (until 20 years) prognosis. Features of interest will include : - Clinical - Biological - Etiological - Echocardiographic - Cardiac magnetic resonance imaging - Genetics (for the prospective cohort) - Anatomopathological The collection of clinical, biological and radiological data will represent an unique source allowing research teams in the coming years to access the data necessary to answer various specific questions (pathophysiological, diagnostic, prognostic) relevant to the state of knowledge on this pathology. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT05911386 -
Multiparametric Echocardiography and Cardiac Biomarkers in Pediatric Inflammatory Heart Diseases
|
||
| Not yet recruiting |
NCT04085718 -
FDG-PET/CT Images Comparing to MRI and Endomyocardial Biopsy in Myocarditis
|
||
| Enrolling by invitation |
NCT05610423 -
Covid-19 Vaccine Associated Myocarditis and Pericarditis in Norway
|
||
| Active, not recruiting |
NCT05195645 -
AbataCept for the Treatment of Immune-cHeckpoint Inhibitors Induced mYocarditiS
|
Phase 2 | |
| Recruiting |
NCT05184114 -
Clinical Significance of Subclinical Myocardial Involvement in Recovered COVID-19 Patients Using Cardiovascular Magnetic Resonance
|
N/A | |
| Recruiting |
NCT04612296 -
The Heart Hive - Cardiomyopathy Study
|
||
| Recruiting |
NCT04673409 -
CMR Imaging of Autoimmune Diseases
|
||
| Recruiting |
NCT05295290 -
A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are Less Than 21 Years Old.
|
Phase 4 | |
| Completed |
NCT03777839 -
PET-FDG in Myocarditis
|
||
| Completed |
NCT06447935 -
Acute Eosinophilic Myocarditis International Registry
|
||
| Not yet recruiting |
NCT05125965 -
Contribution of Cardiac MRI in the Early Diagnosis of Myocarditis Induced by Immunotherapy
|
N/A | |
| Active, not recruiting |
NCT04444128 -
IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION
|
||
| Recruiting |
NCT06158698 -
CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With Colchicine
|
Phase 3 | |
| Recruiting |
NCT05288426 -
Myocarditis Post Vaccination or Multi System Inflammatory Syndrome
|
||
| Recruiting |
NCT05282498 -
Pathophysiologic Mechanism for MYOcarditis in COVID19 VAccinations ("MYOVAx" Study)
|
||
| Recruiting |
NCT03801681 -
ARrhythmias in MYocarditis
|
||
| Recruiting |
NCT06116084 -
Randomized Controlled Study Evaluating the Efficacy of Hypnosis in Nuclear Medicine
|
N/A | |
| Completed |
NCT04413071 -
Cardiac COVID-19 Health Care Workers
|
||
| Recruiting |
NCT05414162 -
Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy
|
||
| Recruiting |
NCT06409585 -
Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition
|